Clearmind Medicine Inc.: Clearmind Medicine Enrolls Last Patient for the First Cohort of its FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder

Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) ("Clearmind" or the "Company"), a clinical-stage biotech company focused on discovery and development ...

Clearmind Medicine Enrolls Last Patient for the First Cohort of its FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder

To date, six patients have been successfully enrolled into the trial, Of these, two patients were enrolled at Johns Hopkins University School of Medicine and four at Yale School of Medicine’s ...
The Bakersfield Californian

Clearmind Medicine Enrolls Last Patient for the First Cohort of its FDA-Approved Phase I/IIa ...

Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel ...
Yale Daily News

New medical school center set to investigate healthy aging with HIV

The interdisciplinary research team at the School of Medicine will work together to explore the effects of factors like ...
The College Fix

Senator denounces ‘outrageous’ use of worker visas to fill Yale, Dartmouth DEI jobs

Dartmouth applied to hire a “program manager” for DEI through the system, according to an X thread by Sen. Schmitt. Likewise, ...

Hardest college to get into in your state

Stacker combed through Niche's 2023 Hardest Colleges to Get Into in America ranking to see which school is the most difficult ...
Hub

Five Johns Hopkins faculty members elected to National Academy of Medicine

Membership recognizes individuals who have demonstrated outstanding professional achievements and commitment to service ...